Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).
BMJ Open
; 9(5): e028486, 2019 05 30.
Article
in En
| MEDLINE
| ID: mdl-31152038
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Autophagy
/
Colchicine
/
Neuroprotective Agents
/
HSP20 Heat-Shock Proteins
/
Proteostasis
/
Amyotrophic Lateral Sclerosis
Type of study:
Clinical_trials
/
Guideline
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
BMJ Open
Year:
2019
Type:
Article
Affiliation country:
Italy